Author Correction: CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells

Karl Petri^#^{1

2}, Weiting Zhang^#^{3

4}, Junyan Ma^#^{3

4

5}, Andrea Schmidts^#^{4

6}, Hyunho Lee^{1

2}, Joy E Horng^{1

2}, Daniel Y Kim^{1

2}, Ibrahim C Kurt^{1

2}, Kendell Clement^{1

2}, Jonathan Y Hsu^{1

2}, Luca Pinello^{1

2}, Marcela V Maus^{4

6}, J Keith Joung^{7

8}, Jing-Ruey Joanna Yeh^{9

10}

Affiliations

¹ Molecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.
² Department of Pathology, Harvard Medical School, Boston, MA, USA.
³ Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA.
⁴ Department of Medicine, Harvard Medical School, Boston, MA, USA.
⁵ Medical College, Dalian University, Dalian, China.
⁶ Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
⁷ Molecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. jjoung@mgh.harvard.edu.
⁸ Department of Pathology, Harvard Medical School, Boston, MA, USA. jjoung@mgh.harvard.edu.
⁹ Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA. jyeh1@mgh.harvard.edu.
¹⁰ Department of Medicine, Harvard Medical School, Boston, MA, USA. jyeh1@mgh.harvard.edu.

^# Contributed equally.

PMID: 33986547
DOI: 10.1038/s41587-021-00939-y

Published Erratum

Author Correction: CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells

Karl Petri et al. Nat Biotechnol. 2022 Feb.

. 2022 Feb;40(2):273.

doi: 10.1038/s41587-021-00939-y.

Authors

Affiliations

¹ Molecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.
² Department of Pathology, Harvard Medical School, Boston, MA, USA.
³ Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA.
⁴ Department of Medicine, Harvard Medical School, Boston, MA, USA.
⁵ Medical College, Dalian University, Dalian, China.
⁶ Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
⁷ Molecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. jjoung@mgh.harvard.edu.
⁸ Department of Pathology, Harvard Medical School, Boston, MA, USA. jjoung@mgh.harvard.edu.
⁹ Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA. jyeh1@mgh.harvard.edu.
¹⁰ Department of Medicine, Harvard Medical School, Boston, MA, USA. jyeh1@mgh.harvard.edu.

^# Contributed equally.

PMID: 33986547
DOI: 10.1038/s41587-021-00939-y

No abstract available

PubMed Disclaimer

Erratum for

CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells.
Petri K, Zhang W, Ma J, Schmidts A, Lee H, Horng JE, Kim DY, Kurt IC, Clement K, Hsu JY, Pinello L, Maus MV, Joung JK, Yeh JJ. Petri K, et al. Nat Biotechnol. 2022 Feb;40(2):189-193. doi: 10.1038/s41587-021-00901-y. Epub 2021 Apr 29. Nat Biotechnol. 2022. PMID: 33927418 Free PMC article.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells

Affiliations

Author Correction: CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells

Authors

Affiliations

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources